Vanderbilt Center for Antibody Therapeutics (VCAT)

April 12, 2012

Targeting post-transplant diabetes

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Richard Powell
January 20, 2012

Digestive disease research bolstered by grant renewal

The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant.

antibodies
October 7, 2011

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

January 6, 2011

Aliquots – VUMC research highlights

June 17, 2008

$2.4 million NIH grant puts Children’s Hospital researcher at forefront of new direction in HIV research

After recent efforts to develop a vaccine to protect against AIDS proved ineffective, the National Institutes of Health announced a change in research direction; and it\’s one that will involve the lab of James Crowe, M.D., professor of Pediatrics, Microbiology and Immunology at the Monroe Carell Jr. Children\’s Hospital at Vanderbilt.